4
Changes in Ownership
Enveric Biosciences, Inc. Filed Acc 0000921895-17-001277
Director gave up 3,683 shares (to pay taxes)
- Director acquired 200 shares (code L)
- Director acquired 10,522 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Eberwein Jeffrey E. Director | 2017-04-17 | Other acquisition | +170 | $6.51 | $1,107 | 83,278 | I |
| Eberwein Jeffrey E. Director | 2017-04-19 | Other acquisition | +2 | $6.51 | $13 | 83,280 | I |
| Eberwein Jeffrey E. Director | 2017-04-21 | Other acquisition | +23 | $6.51 | $150 | 83,303 | I |
| Eberwein Jeffrey E. Director | 2017-04-28 | Other acquisition | +5 | $6.51 | $33 | 83,308 | I |
| Eberwein Jeffrey E. Director | 2017-05-01 | Option exercise | +10,522 | 30,749 | D | ||
| Eberwein Jeffrey E. Director | 2017-05-01 | Shares withheld for taxes | −3,683 | $6.59 | $24,271 | 27,066 | D |
| Derivatives | |||||||
| Eberwein Jeffrey E. Director | 2017-05-01 | Option exercise · Restricted Stock Unit | +10,522 | 0 | D | ||
Loading xslF345X03/form410211002c_05032017.xml…